» Articles » PMID: 21113409

Targeting MYC Expression Through G-Quadruplexes

Overview
Journal Genes Cancer
Specialty Oncology
Date 2010 Nov 30
PMID 21113409
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, the authors describe a novel mechanism for control of MYC expression that involves a four-stranded DNA structure, termed a G-quadruplex, amenable to small molecule targeting. The DNA element involved in this mechanism, the nuclease hypersensitive element III(1) (NHE III(1)), is just upstream of the P1 promoter and is subjected to dynamic stress (negative superhelicity) resulting from transcription. This is sufficient to convert the duplex DNA to a G-quadruplex on the purine-rich strand and an i-motif of the pyrimidine-rich strand, which displaces the activating transcription factors to silence gene expression. Specific proteins have been identified, NM23-H2 and nucleolin, that resolve and fold the G-quadruplex to activate and silence MYC expression, respectively. Inhibition of the activity of NM23-H2 molecules that bind to the G-quadruplex silences gene expression, and redistribution of nucleolin from the nucleolus to the nucleoplasm is expected to inhibit MYC. The authors also describe the mechanism of action of Quarfloxin, a first-in-class G-quadruplex-interactive compound that involves the redistribution of nucleolin from the nucleolus to the nucleoplasm. G-quadruplexes have been best known as test-tube oddities for more than four decades. However, during the past decade, they have emerged as likely players in a number of important biological processes, including transcriptional control. Only time will tell if these odd DNA structures will assume the role of an established receptor class, but it is clear from the scientific literature that there is a dramatic increase in interest in this little-known area in the past few years.

Citing Articles

MYC in cancer: from undruggable target to clinical trials.

Whitfield J, Soucek L Nat Rev Drug Discov. 2025; .

PMID: 39972241 DOI: 10.1038/s41573-025-01143-2.


Higher-Order DNA Secondary Structures and Their Transformations: The Hidden Complexities of Tetrad and Quadruplex DNA Structures, Complexes, and Modulatory Interactions Induced by Strand Invasion Events.

Volker J, Gindikin V, Breslauer K Biomolecules. 2025; 14(12.

PMID: 39766239 PMC: 11673204. DOI: 10.3390/biom14121532.


Sterile Alpha Motif Domain-Containing 5 Suppresses Malignant Phenotypes and Tumor Growth in Breast Cancer: Regulation of Polo-Like Kinase 1 and c-Myc Signaling in a Xenograft Model.

Tuo Y, Ye Y Cureus. 2024; 16(11):e73259.

PMID: 39524172 PMC: 11550111. DOI: 10.7759/cureus.73259.


The 24-hour molecular landscape after exercise in humans reveals MYC is sufficient for muscle growth.

Edman S, Jones Iii R, Jannig P, Fernandez-Gonzalo R, Norrbom J, Thomas N EMBO Rep. 2024; 25(12):5810-5837.

PMID: 39482487 PMC: 11624283. DOI: 10.1038/s44319-024-00299-z.


Combinatorial Anti-Cancer Effect of Polypurine Reverse Hoogsteen Hairpins against and Targeting in Prostate and Pancreatic Cancer Cell Lines.

Valiuska S, Elder K, McKay S, Ciudad C, Noe V, Brooks T Genes (Basel). 2024; 15(10).

PMID: 39457457 PMC: 11507358. DOI: 10.3390/genes15101332.


References
1.
Steeg P, Bevilacqua G, Kopper L, Thorgeirsson U, Talmadge J, Liotta L . Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988; 80(3):200-4. DOI: 10.1093/jnci/80.3.200. View

2.
DCruz C, Gunther E, Boxer R, HARTMAN J, Sintasath L, Moody S . c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med. 2001; 7(2):235-9. DOI: 10.1038/84691. View

3.
Stasik C, Nitta H, Zhang W, Mosher C, Cook J, Tubbs R . Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica. 2010; 95(4):597-603. PMC: 2857189. DOI: 10.3324/haematol.2009.012864. View

4.
Ou T, Lu Y, Zhang C, Huang Z, Wang X, Tan J . Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J Med Chem. 2007; 50(7):1465-74. DOI: 10.1021/jm0610088. View

5.
Dexheimer T, Carey S, Zuohe S, Gokhale V, Hu X, Murata L . NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1). Mol Cancer Ther. 2009; 8(5):1363-77. PMC: 2891668. DOI: 10.1158/1535-7163.MCT-08-1093. View